首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Multilocus Sequence Typing of Neisseria meningitidis Directly from Clinical Samples and Application of the Method to the Investigation of Meningococcal Disease Case Clusters
【2h】

Multilocus Sequence Typing of Neisseria meningitidis Directly from Clinical Samples and Application of the Method to the Investigation of Meningococcal Disease Case Clusters

机译:直接从临床样本中脑膜炎奈瑟菌的多基因座序列分型及其方法在脑膜炎球菌病病例群研究中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Infections associated with Neisseria meningitidis are a major public health problem in England, Wales, and Northern Ireland. Currently, over 40% of cases are confirmed directly from clinical specimens using PCR-based methodologies without an organism being isolated. A nested/seminested multilocus sequence typing (MLST) system was developed at the Health Protection Agency Meningococcal Reference Unit to allow strain characterization beyond the serogroup for cases confirmed by PCR only. This system was evaluated on a panel of 20 meningococcus-positive clinical specimens (3 cerebrospinal fluid and 17 blood samples) from different patients containing various concentrations of meningococcal DNA that had corresponding N. meningitidis isolates. In each case, the sequence type generated from the clinical specimens matched that produced from the corresponding N. meningitidis isolate; the sensitivity of the MLST system was determined to be less than 12 genome copies per PCR. The MLST system was then applied to 15 PCR meningococcus-positive specimens (2 cerebrospinal fluid and 13 blood samples), each from a different patient, involved in three case clusters (two serogroup B and one serogroup W135) for which no corresponding N. meningitidis organisms had been isolated. In each case, an MLST sequence type was generated, allowing the accurate assignment of individual cases within each of the case clusters. In summary, the adaptation of the N. meningitidis MLST to a sensitive nested/seminested format for strain characterization directly from clinical specimens provides an important tool for surveillance and management of meningococcal infection.
机译:在英格兰,威尔士和北爱尔兰,与脑膜炎奈瑟菌相关的感染是主要的公共卫生问题。目前,超过40%的病例是使用基于PCR的方法直接从临床标本中确认的,而没有分离出生物。卫生保护局脑膜炎球菌参考单位开发了嵌套/半封闭多基因座序列分型(MLST)系统,以仅针对通过PCR确诊的病例进行血清群以外的菌株鉴定。在一组来自不同患者的20例脑膜炎球菌阳性临床标本(3例脑脊液和17份血液样本)上对该系统进行了评估,这些样本包含各种浓度的脑膜炎球菌DNA,并具有相应的脑膜炎奈瑟氏菌分离株。在每种情况下,临床标本产生的序列类型与相应的脑膜炎奈瑟氏菌分离株产生的序列类型匹配。 MLST系统的灵敏度被确定为每次PCR小于12个基因组拷贝。然后将MLST系统应用于15个PCR脑膜炎球菌阳性样本(2个脑脊液和13个血液样本),每个样本来自不同的患者,涉及三个病例组(两个B血清群和一个W135血清群),没有相应的脑膜炎奈瑟氏球菌。生物体已被分离。在每种情况下,都会生成MLST序列类型,从而可以在每个案例群中准确分配各个案例。总而言之,脑膜炎奈瑟氏菌MLST适应于直接从临床标本中鉴定菌株的敏感的嵌套/半透明形式,为监测和管理脑膜炎球菌感染提供了重要的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号